There is a significant association between the rise of populism across Europe and the level of mistrust around vaccines, according to a study by Queen Mary University of London.
Mar 1, 2019
2
132
Political events can take a serious toll on mental health, a doctor has warned in the journal BMJ Case Reports, after treating a man with a brief episode of acute psychosis, triggered by the 2016 Referendum on Brexit—the ...
Oct 1, 2019
0
441
The hospitalization rate for acute cardiovascular disease (CVD) events in a large southern California health system was 1.62 times higher in the two days immediately after the 2016 presidential election when compared with ...
Oct 12, 2020
0
65
Offering mailed nicotine replacement therapy (NRT) and Quitline support to patients encouraged almost one-third of smokers to quit before their elective surgery, according to research published today by the Medical Journal ...
Apr 4, 2022
0
1
India on Thursday announced a national healthcare scheme for half a billion of its poorest citizens in a major giveaway to voters in the final budget before a general election.
Feb 1, 2018
0
13
Concerns about health and rising death rates may have helped tilt the 2016 presidential election in favor of Donald J. Trump, according to an analysis of voting patterns and mortality rates in counties across the U.S.
Sep 5, 2018
0
127
The German government is setting in motion plans to legalize the sale of cannabis for recreational purposes, aiming to have legislation ready later this year.
Jun 13, 2022
0
0
Mongolia will maintain strict coronavirus regulations until a vaccine is found, the prime minister said Monday, raising the prospect of the country being locked down for months to come.
May 25, 2020
0
6
Superior memory function in a group of older adults dubbed "SuperAgers" may be an indicator that a person is less likely to develop delirium after elective surgery, researchers from Massachusetts General Hospital (MGH) have ...
Jul 14, 2022
0
13
The manufacturers of two COVID-19 vaccines developed by Chinese pharmaceutical firm Sinovac and Oxford-AstraZeneca filed the first applications Friday for regulatory approval in hard-hit Brazil, officials said.
Jan 9, 2021
0
2
